Skip to main content
  • Accessibility
  • Headlines
  • Coronavirus-News
  • Get-Hooked
  • Technology
  • Education
  • Employment
  • Parasports
  • Ask Bhavna
  • NHBrandView
  • Independent Living
  • Lifestyle
  • NH Videos
×
Newz Hook – Changing Attitudes towards Disability Logo
  • Stories
  • Videos
  • Inclusive 2023
  • NH Voice
  • Login
COVID-19 Notification by Government in Accessible Format

Accessibility Tools

Text Size:

Contrast Scheme:

  • C
  • C

Reset

  • Home
  • Headlines
  • India to begin plasma therapy trials to treat COVID-19 patients

India to begin plasma therapy trials to treat COVID-19 patients

Blood test
Headlines April 11, 2020
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

India is preparing to start clinical trials to treat coronavirus disease (Covid-19) patients with plasma therapy. This involves drawing antibody-rich blood of COVID-19 survivors to treat the sick. The therapy has shown promise in treating patients according to leading medical journals.

India’s top biomedical research organisation, the Indian Council of Medical Research (ICMR), is working on the guidelines to conduct the trial. Once ready, this will be taken for approvals to conduct trials.

“Since it is a new drug, it has to be given on a clinical trial mode, for which the approval of the drugs controller is a must. Once the draft is ready, then ICMR, as per protocol, will approach the DCGI, for approval to conduct a clinical trial in the country,” said Dr Manoj V Murhekar, Director, National Institute of Epidemiology, Chennai.

The therapy has shown consistent and safe effects on a small group of 10 patients in China who were critically ill. They started showing significant improvements after a single dose.

To begin with we will be selecting patients who would be given this medicine on a study mode. The process will be expedited as during pandemics you don’t have to recruit a large number of patients for such trials. A small number is good enough, and the DCGI is quick to give approvals for anything Covid-19 related these days, so we are expecting to start soon. – Dr Manoj V Murhekar, Director, National Institute of Epidemiology

The ICMR has directed states to focus on hot spots and clusters to conduct the trials.

Two labs have already started work on the virus and the government hopes to understand the virus better.

Support us to make NewzHook Sustainable – Make a Contribution Today

We need your continued support to enable us work towards Changing Attitudes towards Disability. Help us in our attempt to share the voices of people with disabilities that enable them to participate in the society on an equal footing!

Contribute to Newz Hook

NH Videos

Healing pain through art - Dr. Anubha Mahajan, Founder Chronic Pain India

Contribue to Newz Hook |Disability news. Support us to make NewzHook Sustainable – Make a Contribution Today.

Newsletter

 Subscribe to our Newsletter

Want to feature disability stories or share disability news with the disabled community? Write to:

editor@newzhook.com

Newz Hook - Accessible News

Download App Now!

Videos

View More

Education

This transition program assists young adults with autism in developing meaningful goals

Get-hooked

Deaf actor Abhinaya looks forward to global release of first English feature film

Get-hooked

Understanding Fragile X syndrome

Education

Neuroscientist Joey Ramp is breaking down barriers for disabled STEM students with service dogs

Newz Hook Logo

About Newz Hook

Newz Hook | Disability News - media site focusing on Disability Stories and Changing Attitudes towards Disability globally. We highlight disability news, offer inclusive solutions and create accessible collaborations. Our focus is to have Inclusion Champions from across the globe who will share disability stories and news.
Lets come together to change attitudes towards disability!

Newz Hook is reader-supported. When you buy through links on our site, we may earn an affiliate commission.

Follow us on:

Related Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Partner with Newz Hook
  • Embed Newz Hook Timeline
  • Affiliate disclosure
  • Accessibility Statement
  • Contribute to Newz Hook

Our Awards

Zero Project Award Winner 2018
Back To Top
© 2023 All Right Reserved. Inclusive News India Private Limited.

Ask Bhavna

All fields are mandatory unless specified as optional.